MAIA: MAIA Biotechnology Inc

MAIA News

• 12:23 Maia Biotechnology stock soars after FDA grants Fast Track designation
• 12:17 FDA grants fast track designation for MAIA’s lung cancer drug
• 11:01 MAIA Biotechnology’s 41% decline validates InvestingPro’s overvalued call
• 13:31 Maia Biotechnology stock soars after publishing promising preclinical data
• 13:23 MAIA Biotechnology publishes preclinical data on cancer drug candidates
• 13:20 MAIA Biotechnology doses first patient in Taiwan for NSCLC trial
• 10:23 Maia Biotechnology enters stock purchase agreement for up to $587,905 with Prevail Partners
• 12:25 MAIA Biotechnology appoints HCC experts to scientific advisory board
• 13:18 MAIA Biotechnology partners with Roche for cancer treatment studies
• 13:00 MAIA Biotechnology to Present at BIO International Convention 2025
• 15:17 MAIA reports NSCLC patient response in Phase 2 trial
• 13:04 Maia Biotechnology stock rises following positive trial results
• 12:13 MAIA reports extended survival in lung cancer trial
• 20:37 MAIA Biotechnology secures $669,500 in private placement
• 15:16 MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
• 14:28 MAIA Biotechnology Announces Director Participation in Recent Private Placement